Seelos Therapeutics, Inc.'s next confirmed earnings release is scheduled for November 6, 2026.
| Earnings Date | 11/6/2026 |
As of the close on October 22, 2026, Seelos Therapeutics, Inc.'s stock has declined approximately 99.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 20.07.
| 52-Week Price Change | -99.00% |
| 200-Day Moving Average | 20.07 |
Seelos Therapeutics, Inc.'s most recent stock split took place on September 27, 2024 with a 16:1 split ratio.
| Last Split Date | 9/27/2024 |
| Split Ratio | 16:1 |